Dr. Jason Brant Carmel, MD, PhD

Jason B. Carmel, MD, PhD, is a child neurologist and motor system neuroscientist dedicated to improving movement and function in individuals with central nervous system injuries. He specializes in treating children, adolescents, and adults with conditions such as cerebral palsy at the Movement Recovery Clinic and evaluates infants with delayed motor milestones in the Infant Movement Evaluation Clinic. Dr. Carmel works closely with patients and their families to develop personalized treatment plans that align with their goals for mobility, independence, and participation in daily life.

Dr. Carmel is Chief of the Division of Child Neurology and Executive Director of the Weinberg Family Cerebral Palsy Center at NewYork-Presbyterian/Columbia University Irving Medical Center. Additionally, Dr. Carmel directs the Movement Recovery Laboratory, where he leads groundbreaking research on activity-based therapies that harness the body’s own capacity for recovery. His work explores innovative …approaches, including brain and spinal cord stimulation and intensive behavioral training, to strengthen neural connections and restore movement. His research has demonstrated that stimulating intact pathways after injury can enhance their function, promote new connections, and improve motor skills.

Dr. Carmel is committed to bridging the gap between research and clinical care. By translating discoveries from the lab into more effective therapies, he is shaping the future of treatment for patients with cerebral palsy and other movement disorders, across their lifespan. His ultimate goal as a physician-scientist is to develop and refine therapies that help individuals regain mobility, confidence, and quality of life.

A leader in neurorehabilitation, Dr. Carmel is a standing NIH study section member, program chair of the American Society for Neurorehabilitation, and a steering committee member of the Cerebral Palsy Research Network. He also serves as a scientific and medical advisor to companies advancing neuromodulation technologies. His work is supported by the National Institutes of Health and private foundations.